wait 18 weeks or less from referral to entering a course of IAPT treatment* Full implementation of Failure to Review of Service 5% of the Actual Monthly Where both an effective achieve full Quality Performance Monthly Value for the Specialised system for implementation Reports Services provided under Services chemotherapy across as described Service Specification and Cancer all relevant clinical under Service B15/S/a (Cancer: apply teams within the Specification Chemotherapy (Adult) Provider (other than B15/S/a per month, until full those dealing with Cancer: implementation is children, teenagers and Chemotherapy achieved young adults) across all (Adult) by 31 tumour sites March 2017 Full implementation of Failure to Review of Service 5% of the Actual Monthly Where both an effective achieve full Quality Performance Monthly Value for the Specialised system for implementation Reports Services provided under Services chemotherapy across as described Service Specification and Cancer all relevant clinical under Service B15/S/b Cancer: apply within the Provider Specification Chemotherapy dealing with children, B15/S/b (Children, Teenagers teenagers and young Cancer: and Young Adults) per adults across all tumour Chemotherapy month, until full sites (Children, implementation is Teenagers and achieved Young Adults) by 30 September 2017
wait 18 weeks or less from referral to entering a course of IAPT treatment* Full implementation of an effective system for chemotherapy across all relevant clinical teams within the Provider (other than those dealing with children, teenagers and young adults) across all tumour sites Failure to achieve full implementation as described under Service Specification B15/S/a Cancer: Chemotherapy (Adult) by 31 March 2017 Review of Service Quality Performance Reports 5% of the Actual Monthly Value for the Services provided under Service Specification B15/S/a (Cancer: Chemotherapy (Adult) per month, until full implementation is achieved Monthly Where both Specialised Services and Cancer apply Full implementation of an effective system for chemotherapy across all relevant clinical within the Provider dealing with children, teenagers and young adults across all tumour sites Failure to achieve full implementation as described under Service Specification B15/S/b Cancer: Chemotherapy (Children, Teenagers and Young Adults) by 30 September 2017 Review of Service Quality Performance Reports 5% of the Actual Monthly Value for the Services provided under Service Specification B15/S/b Cancer: Chemotherapy (Children, Teenagers and Young Adults) per month, until full implementation is achieved Monthly Where both Specialised Services and Cancer apply